CASI Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - CASI Pharmaceuticals Inc - Alpha Spread
C

CASI Pharmaceuticals Inc
NASDAQ:CASI

Watchlist Manager
CASI Pharmaceuticals Inc
NASDAQ:CASI
Watchlist
Price: 6.54 USD -3.25% Market Closed
Market Cap: 87.6m USD
Have any thoughts about
CASI Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

CASI Price Targets Summary
CASI Pharmaceuticals Inc

Wall Street analysts forecast CASI stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CASI is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
7% Downside
Average
Price Target
6.12 USD
6% Downside
Highest
Price Target
6.3 USD
4% Downside

CASI Last Price Targets
CASI Pharmaceuticals Inc

The latest public price target was made on May 15, 2024 by Sean Lee from H.C. Wainwright , who expects CASI stock to drop by 8% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Sean Lee
H.C. Wainwright
6 USD
Downside 8%
4 months ago
May 15, 2024
CASI Pharmaceuticals (CASI) PT Lowered to $6 at H.C. Wainwright
StreetInsider
Sean Lee
H.C. Wainwright
Price Target 6 USD
Upside/Downside 8%
View Source
CASI Pharmaceuticals Inc Competitors:
Price Targets
BIO
Biotest AG
20% Downside
NANO
Nanobiotix SA
159% Upside
BIOPOR
Bioporto A/S
59% Upside
AGIO
Agios Pharmaceuticals Inc
21% Upside
BCRX
BioCryst Pharmaceuticals Inc
81% Upside
INSM
Insmed Inc
20% Upside
BBIO
BridgeBio Pharma Inc
87% Upside
PHM
Pharma Mar SA
14% Upside

Revenue
Forecast

Revenue Estimate
CASI Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for CASI Pharmaceuticals Inc's revenue is 126%. The projected CAGR for the next 3 years is 28%.

126%
Past Growth
28%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
CASI Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
CASI Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CASI's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for CASI is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

What is CASI Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for CASI Pharmaceuticals Inc's revenue is 126%. The projected CAGR for the next 3 years is 28%.

Back to Top